Drug profile · INN
ebola vaccine (ad26.zebov-gp [recombinant])
ZABDENO
ebola vaccine (ad26.zebov-gp [recombinant]) (ZABDENO) is a envelope glycoprotein vaccine antigen.
EMA: withdrawn Antiinfectives for systemic use (J07) J07
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ebola vaccine (ad26.zebov-gp [recombinant])
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
ebola vaccine (ad26.zebov-gp [recombinant]) (ZABDENO) is a envelope glycoprotein vaccine antigen.
Key facts
INN ebola vaccine (ad26.zebov-gp [recombinant])
Brand ZABDENO
Mechanism Envelope glycoprotein vaccine antigen
Target Envelope glycoprotein
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07
Mechanism of action
Envelope glycoprotein vaccine antigen
Primary target: Envelope glycoprotein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ebola vaccine (ad26.zebov-gp [recombinant])?
ebola vaccine (ad26.zebov-gp [recombinant]) (ZABDENO) is a envelope glycoprotein vaccine antigen.
What is the brand name for ebola vaccine (ad26.zebov-gp [recombinant])?
ZABDENO is a marketed brand name for ebola vaccine (ad26.zebov-gp [recombinant]). Check FDA Drugs@FDA for the current US label holder and prescribing information.